Portal de Periódicos da CAPES

No effects of bisphosphonates on the human fetus

2003; Wiley; Volume: 67; Issue: 3 Linguagem: Inglês

10.1002/bdra.10016

2472-1727

A.R. Rutgers‐Verhage, T.W. deVries, M.J.L. Torringa,

Congenital Anomalies and Fetal Surgery

Birth Defects Research Part A: Clinical and Molecular TeratologyVolume 67, Issue 3 p. 203-204 Correspondence No effects of bisphosphonates on the human fetus A.R. Rutgers-Verhage, A.R. Rutgers-Verhage Department of Pediatrics Medical Centre Leeuwarden Leeuwarden, The NetherlandsSearch for more papers by this authorT.W. deVries, Corresponding Author T.W. deVries Department of Pediatrics Medical Centre Leeuwarden Leeuwarden, The NetherlandsDepartment of Pediatrics, Medisch Centrum Leeuwarden Noord, Mr. P.J. Troelstraweg 78, 8917 CR Leeuwarden, The Netherlands===Search for more papers by this authorM.J.L. Torringa, M.J.L. Torringa Department of Pediatrics University Hospital Groningen, The NetherlandsSearch for more papers by this author A.R. Rutgers-Verhage, A.R. Rutgers-Verhage Department of Pediatrics Medical Centre Leeuwarden Leeuwarden, The NetherlandsSearch for more papers by this authorT.W. deVries, Corresponding Author T.W. deVries Department of Pediatrics Medical Centre Leeuwarden Leeuwarden, The NetherlandsDepartment of Pediatrics, Medisch Centrum Leeuwarden Noord, Mr. P.J. Troelstraweg 78, 8917 CR Leeuwarden, The Netherlands===Search for more papers by this authorM.J.L. Torringa, M.J.L. Torringa Department of Pediatrics University Hospital Groningen, The NetherlandsSearch for more papers by this author First published: 20 March 2003 https://doi.org/10.1002/bdra.10016Citations: 23Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES Geddes AD, D'Souza SM, Ebetino FH, Ibbotson KJ. 1994. Bisphosphonates structure-activity relationships and therapeutic implications. Bone Miner Res 8: 265–306. Gerver WJM, de Bruin R. 2001. Paediactric morphometrics. Maastricht: University Press. Hannuniemi R, Lauren L, Puolijoki H. 1991. Clodronate: an effective agent for the treatment of increased bone resorption. Drugs Today (Barc) 27: 375–390. Liberman UA, Weiss SR, Broll J, Minne HW, Quan H, Bell NH, Rodriquez-Portales J, Downs R, Dequeker J, Favus M, Seemen E, Recker R, Capizzi T, Santora A, Lombardi A, Shah R, Hirsch L, Karpf D. 1995. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med 333: 1437–1443. Minsker DH, Manson JM, Peter CP. 1993. Effects of the bisphosphonate, Alendronate, on parturition in the rat. Toxicol Appl Pharmacol 121: 217–223. Patlas N, Golomb G, Yaffe P, Pinto T, Breuer E, Ornoy A. 1999. Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats. Teratology 60: 68–73. Wronski TJ, Dann LM, Qi H, Yen CF. 1993. Skeletal effects of withdrawal of estrogen and diphosphonate treatment in ovariectomized rats. Calcif Tissue Int 53: 210–216. Citing Literature Volume67, Issue3March 2003Pages 203-204 ReferencesRelatedInformation